Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia

Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia

The invention belongs to the technical field of medicines, and provides application of endogenous orphin, namely N/OFQ, as a serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia in order to solve the problem that effective indexes which can be directly detected fro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HAN YI, GUO ZHENG, ZHANG LINZHONG, XIE MENGLI, LI JING, SU JING
Format: Patent
Sprache:chi ; eng
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HAN YI
GUO ZHENG
ZHANG LINZHONG
XIE MENGLI
LI JING
SU JING
description The invention belongs to the technical field of medicines, and provides application of endogenous orphin, namely N/OFQ, as a serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia in order to solve the problem that effective indexes which can be directly detected from blood do not exist in the existing definite diagnosis of the asymptomatic myocardial ischemia SMI. The invention discloses application of endogenous orphin. The endogenous orphin is used for preparing a diagnostic reagent or a kit for detecting diabetes mellitus complicated with asymptomatic myocardial ischemia. The serum N/OFQ in the body of a patient with diabetes mellitus combined with SMI is obviously increased and is positively correlated with the severity degree of coronary artery lesions, so that the N/OFQ is determined to possibly become a potential index for predicting SMI. In view that N/OFQ can play a role in acute myocardial ischemia, N/OFQ becomes possible to serve as a new index for predicting the c
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN112730849A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN112730849A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN112730849A3</originalsourceid><addsrcrecordid>eNqNzEEKwjAQheFuXIh6h_EAgrWCuixFceXKfZmmUzOYZEKSIsXLG9ADuHqb_3vz4l17b1hhYnEgA5Dr5UFOxggSvGYHGCFSGC10LBbDkwIMEqBn7ChRBEvGcMq9Evu9oh5enHSWk_Upo8QK7CQKQ1YGOCpNlnFZzAY0kVa_XRTry_neXDfkpaXoUZGj1Da3stwdqu1xf6qrf5oPUq9Irw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia</title><source>esp@cenet</source><creator>HAN YI ; GUO ZHENG ; ZHANG LINZHONG ; XIE MENGLI ; LI JING ; SU JING</creator><creatorcontrib>HAN YI ; GUO ZHENG ; ZHANG LINZHONG ; XIE MENGLI ; LI JING ; SU JING</creatorcontrib><description>The invention belongs to the technical field of medicines, and provides application of endogenous orphin, namely N/OFQ, as a serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia in order to solve the problem that effective indexes which can be directly detected from blood do not exist in the existing definite diagnosis of the asymptomatic myocardial ischemia SMI. The invention discloses application of endogenous orphin. The endogenous orphin is used for preparing a diagnostic reagent or a kit for detecting diabetes mellitus complicated with asymptomatic myocardial ischemia. The serum N/OFQ in the body of a patient with diabetes mellitus combined with SMI is obviously increased and is positively correlated with the severity degree of coronary artery lesions, so that the N/OFQ is determined to possibly become a potential index for predicting SMI. In view that N/OFQ can play a role in acute myocardial ischemia, N/OFQ becomes possible to serve as a new index for predicting the c</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210430&amp;DB=EPODOC&amp;CC=CN&amp;NR=112730849A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210430&amp;DB=EPODOC&amp;CC=CN&amp;NR=112730849A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAN YI</creatorcontrib><creatorcontrib>GUO ZHENG</creatorcontrib><creatorcontrib>ZHANG LINZHONG</creatorcontrib><creatorcontrib>XIE MENGLI</creatorcontrib><creatorcontrib>LI JING</creatorcontrib><creatorcontrib>SU JING</creatorcontrib><title>Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia</title><description>The invention belongs to the technical field of medicines, and provides application of endogenous orphin, namely N/OFQ, as a serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia in order to solve the problem that effective indexes which can be directly detected from blood do not exist in the existing definite diagnosis of the asymptomatic myocardial ischemia SMI. The invention discloses application of endogenous orphin. The endogenous orphin is used for preparing a diagnostic reagent or a kit for detecting diabetes mellitus complicated with asymptomatic myocardial ischemia. The serum N/OFQ in the body of a patient with diabetes mellitus combined with SMI is obviously increased and is positively correlated with the severity degree of coronary artery lesions, so that the N/OFQ is determined to possibly become a potential index for predicting SMI. In view that N/OFQ can play a role in acute myocardial ischemia, N/OFQ becomes possible to serve as a new index for predicting the c</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzEEKwjAQheFuXIh6h_EAgrWCuixFceXKfZmmUzOYZEKSIsXLG9ADuHqb_3vz4l17b1hhYnEgA5Dr5UFOxggSvGYHGCFSGC10LBbDkwIMEqBn7ChRBEvGcMq9Evu9oh5enHSWk_Upo8QK7CQKQ1YGOCpNlnFZzAY0kVa_XRTry_neXDfkpaXoUZGj1Da3stwdqu1xf6qrf5oPUq9Irw</recordid><startdate>20210430</startdate><enddate>20210430</enddate><creator>HAN YI</creator><creator>GUO ZHENG</creator><creator>ZHANG LINZHONG</creator><creator>XIE MENGLI</creator><creator>LI JING</creator><creator>SU JING</creator><scope>EVB</scope></search><sort><creationdate>20210430</creationdate><title>Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia</title><author>HAN YI ; GUO ZHENG ; ZHANG LINZHONG ; XIE MENGLI ; LI JING ; SU JING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN112730849A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>HAN YI</creatorcontrib><creatorcontrib>GUO ZHENG</creatorcontrib><creatorcontrib>ZHANG LINZHONG</creatorcontrib><creatorcontrib>XIE MENGLI</creatorcontrib><creatorcontrib>LI JING</creatorcontrib><creatorcontrib>SU JING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAN YI</au><au>GUO ZHENG</au><au>ZHANG LINZHONG</au><au>XIE MENGLI</au><au>LI JING</au><au>SU JING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia</title><date>2021-04-30</date><risdate>2021</risdate><abstract>The invention belongs to the technical field of medicines, and provides application of endogenous orphin, namely N/OFQ, as a serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia in order to solve the problem that effective indexes which can be directly detected from blood do not exist in the existing definite diagnosis of the asymptomatic myocardial ischemia SMI. The invention discloses application of endogenous orphin. The endogenous orphin is used for preparing a diagnostic reagent or a kit for detecting diabetes mellitus complicated with asymptomatic myocardial ischemia. The serum N/OFQ in the body of a patient with diabetes mellitus combined with SMI is obviously increased and is positively correlated with the severity degree of coronary artery lesions, so that the N/OFQ is determined to possibly become a potential index for predicting SMI. In view that N/OFQ can play a role in acute myocardial ischemia, N/OFQ becomes possible to serve as a new index for predicting the c</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN112730849A
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title Application of endogenous orphin as serum biomarker for diabetes mellitus complicated with asymptomatic myocardial ischemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A59%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAN%20YI&rft.date=2021-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN112730849A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true